rs7972574
Variant names:
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_002834.5(PTPN11):c.14+25G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0204 in 1,501,108 control chromosomes in the GnomAD database, including 995 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.052 ( 490 hom., cov: 33)
Exomes 𝑓: 0.017 ( 505 hom. )
Consequence
PTPN11
NM_002834.5 intron
NM_002834.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.41
Publications
3 publications found
Genes affected
PTPN11 (HGNC:9644): (protein tyrosine phosphatase non-receptor type 11) The protein encoded by this gene is a member of the protein tyrosine phosphatase (PTP) family. PTPs are known to be signaling molecules that regulate a variety of cellular processes including cell growth, differentiation, mitotic cycle, and oncogenic transformation. This PTP contains two tandem Src homology-2 domains, which function as phospho-tyrosine binding domains and mediate the interaction of this PTP with its substrates. This PTP is widely expressed in most tissues and plays a regulatory role in various cell signaling events that are important for a diversity of cell functions, such as mitogenic activation, metabolic control, transcription regulation, and cell migration. Mutations in this gene are a cause of Noonan syndrome as well as acute myeloid leukemia. [provided by RefSeq, Aug 2016]
PTPN11 Gene-Disease associations (from GenCC):
- LEOPARD syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Genomics England PanelApp
- Noonan syndromeInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- Noonan syndrome 1Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae), Genomics England PanelApp, PanelApp Australia
- Noonan syndrome with multiple lentiginesInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
- metachondromatosisInheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
- cardiofaciocutaneous syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- Costello syndromeInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 12-112419150-G-C is Benign according to our data. Variant chr12-112419150-G-C is described in ClinVar as Benign. ClinVar VariationId is 40478.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.147 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0522 AC: 7941AN: 152032Hom.: 487 Cov.: 33 show subpopulations
GnomAD3 genomes
AF:
AC:
7941
AN:
152032
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0189 AC: 1855AN: 97960 AF XY: 0.0182 show subpopulations
GnomAD2 exomes
AF:
AC:
1855
AN:
97960
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0168 AC: 22652AN: 1348968Hom.: 505 Cov.: 30 AF XY: 0.0164 AC XY: 10892AN XY: 664836 show subpopulations
GnomAD4 exome
AF:
AC:
22652
AN:
1348968
Hom.:
Cov.:
30
AF XY:
AC XY:
10892
AN XY:
664836
show subpopulations
African (AFR)
AF:
AC:
4298
AN:
27334
American (AMR)
AF:
AC:
644
AN:
31904
Ashkenazi Jewish (ASJ)
AF:
AC:
82
AN:
23776
East Asian (EAS)
AF:
AC:
145
AN:
31008
South Asian (SAS)
AF:
AC:
1526
AN:
75426
European-Finnish (FIN)
AF:
AC:
529
AN:
39018
Middle Eastern (MID)
AF:
AC:
120
AN:
3948
European-Non Finnish (NFE)
AF:
AC:
13921
AN:
1060652
Other (OTH)
AF:
AC:
1387
AN:
55902
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1071
2142
3214
4285
5356
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
608
1216
1824
2432
3040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0524 AC: 7966AN: 152140Hom.: 490 Cov.: 33 AF XY: 0.0505 AC XY: 3755AN XY: 74388 show subpopulations
GnomAD4 genome
AF:
AC:
7966
AN:
152140
Hom.:
Cov.:
33
AF XY:
AC XY:
3755
AN XY:
74388
show subpopulations
African (AFR)
AF:
AC:
6216
AN:
41518
American (AMR)
AF:
AC:
471
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
AC:
11
AN:
3470
East Asian (EAS)
AF:
AC:
43
AN:
5156
South Asian (SAS)
AF:
AC:
84
AN:
4828
European-Finnish (FIN)
AF:
AC:
115
AN:
10602
Middle Eastern (MID)
AF:
AC:
6
AN:
292
European-Non Finnish (NFE)
AF:
AC:
920
AN:
67966
Other (OTH)
AF:
AC:
96
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
369
738
1107
1476
1845
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
84
168
252
336
420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
76
AN:
3450
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Metachondromatosis Benign:1
Feb 01, 2025
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Juvenile myelomonocytic leukemia Benign:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Noonan syndrome Benign:1
May 29, 2014
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.